Insider Trading activities at Syneos Health, Inc. (INCR)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Syneos Health, Inc. (INCR) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Syneos Health, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1610950.

Total stock buying since 2015: $915,386.
Total stock sales since 2015: $16,367,309,167.
Total stock option exercises since 2015: $22,479,129.


 1   2 
35 insiders reported insider trading activities at Syneos Health, Inc. (INCR):
Insider trading activities of Parks Robert
Insider trading activities of Thl Holdco, Llc
Insider trading activities of Keefe Michelle
Insider trading activities of Brooks Michael Lee
Insider trading activities of Advent International Gpe Vii-c Limited Partnership
Insider trading activities of Dineen John M.
Insider trading activities of Advent International Gpe Vii-d Limited Partnership
Insider trading activities of Gibertini Michael
Insider trading activities of Advent International Gpe Vii-e Limited Partnership
Insider trading activities of Rush Gregory S
Insider trading activities of Thl Equity Fund Vii Investors (inventiv), L.p.
Insider trading activities of Breckon Robert W
Insider trading activities of Macdonald D. Jamie
Insider trading activities of Colvin Paul
Insider trading activities of Nelson Joshua M
Insider trading activities of Harty Linda S
Insider trading activities of 1829356 Ontario Ltd
Insider trading activities of Ogle James T.
Insider trading activities of Advent International Gpe Vii-h Limited Partnership
Insider trading activities of Advent International Gpe Viii-b Limited Partnership
Insider trading activities of Advent International Gpe Vii-g Limited Partnership
Insider trading activities of Maldonado John L.
Insider trading activities of Gaenzle Christopher L
Insider trading activities of Macdonald Alistair
Insider trading activities of Kralowetz Donna Hildebrand
Insider trading activities of Advent Partners Gpe Viii-a Limited Partnership
Insider trading activities of Advent Partners Gpe Vii-a 2014 Cayman Limited Partnership
Insider trading activities of Burgstahler David F
Insider trading activities of Monaghan Matthew E.
Insider trading activities of Olefson Jonathan
Insider trading activities of Inc Research Mezzanine Co-invest, Llc
Insider trading activities of Allen Tom
Insider trading activities of Advent International Gpe Viii-i Limited Partnership
Insider trading activities of Advent International Gpe Vii, Llc
Insider trading activities of Meggs Jason M.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Syneos Health, Inc. (INCR).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2022 0 $0 24,958 $1,855,260 0 $0
2021 0 $0 129,347,392 $10,179,776,918 82,199 $1,960,125
2020 13,546 $690,683 68,040,861 $4,095,592,634 83,048 $701,471
2019 0 $0 14,840 $786,781 14,840 $125,397
2018 4,400 $181,516 6,001,470 $298,440,270 0 $0
2017 0 $0 346,654 $19,204,417 429,781 $5,165,813
2016 1,000 $43,187 13,786,952 $606,445,106 731,926 $8,103,778
2015 0 $0 30,501,607 $1,165,207,781 635,739 $6,422,545

Table 2. Monthly summary of insider trading at Syneos Health, Inc. (INCR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2022-07 0 $0 23,703 $1,745,441 0 $0
2022-05 0 $0 200 $14,869 0 $0
2022-01 0 $0 1,055 $94,950 0 $0
2021-12 0 $0 6,197 $609,396 0 $0
2021-09 0 $0 9,471 $899,571 0 $0
2021-08 0 $0 40,263 $3,557,817 35,553 $1,520,246
2021-07 0 $0 830 $74,468 660 $29,422
2021-06 0 $0 49,206,167 $3,995,616,055 9,557 $410,457
2021-05 0 $0 34,735,622 $2,814,974,797 0 $0
2021-04 0 $0 22,775 $1,851,472 0 $0
2021-03 0 $0 45,237,834 $3,355,552,321 36,429 $0
2021-02 0 $0 73,345 $5,534,729 0 $0
2021-01 0 $0 14,888 $1,106,292 0 $0
2020-12 0 $0 31,370,946 $1,922,424,821 0 $0
2020-11 0 $0 7,656 $507,760 0 $0
2020-09 0 $0 36,597,686 $2,168,778,870 0 $0
2020-08 0 $0 10,289 $669,464 0 $0
2020-07 8,691 $513,725 48,196 $2,883,575 46,696 $701,471
2020-05 0 $0 2,500 $150,000 0 $0
2020-04 0 $0 3,588 $178,144 0 $0
2020-03 4,855 $176,958 0 $0 36,352 $0
2019-02 0 $0 14,840 $786,781 14,840 $125,397
2018-12 4,400 $181,516 0 $0 0 $0
2018-08 0 $0 6,000,000 $298,380,000 0 $0

Table 3. Detailed insider trading at Syneos Health, Inc. (INCR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2022-07-28 Brooks Michael Lee (Chief Operating Officer) Sale 1,502 78.00 117,156
2022-07-21 Brooks Michael Lee (Chief Operating Officer) Sale 1,502 76.00 114,152
2022-07-20 Olefson Jonathan (General Counsel & Corp Secty) Sale 2,215 75.00 166,125
2022-07-19 Brooks Michael Lee (Chief Operating Officer) Sale 1,502 74.00 111,148
2022-07-18 Keefe Michelle (Chief Executive Officer) Sale 8,333 72.81 606,725
2022-07-18 Meggs Jason M. (Chief Financial Officer) Sale 7,500 72.81 546,075
2022-07-08 Kralowetz Donna Hildebrand (EVP, Chief Accounting Officer) Sale 1,149 73.16 84,060
2022-05-31 Monaghan Matthew E. (Director) Sale 200 74.35 14,869
2022-01-31 Kralowetz Donna Hildebrand (SVP, Chief Accounting Officer) Sale 1,055 90.00 94,950
2021-12-30 Brooks Michael Lee (See remarks) Sale 93 103.00 9,579
2021-12-23 Olefson Jonathan (General Counsel & Corp Secty) Sale 1,889 100.95 190,694
2021-12-22 Brooks Michael Lee (See remarks) Sale 93 99.00 9,207
2021-12-20 Harty Linda S (Director) Sale 4,122 97.02 399,916
2021-09-03 Kralowetz Donna Hildebrand (SVP, Chief Accounting Officer) Sale 248 94.30 23,386
2021-09-03 Meggs Jason M. (Chief Financial Officer) Sale 9,223 95.00 876,185
2021-08-03 Macdonald Alistair (Chief Executive Officer) Sale 35,553 88.16 3,134,388
2021-08-03 Macdonald Alistair (Chief Executive Officer) Option Ex 35,553 42.76 1,520,246
2021-08-02 Macdonald Alistair (Chief Executive Officer) Sale 4,710 89.90 423,429
2021-07-16 Monaghan Matthew E. (Director) Sale 170 88.64 15,068
2021-07-06 Meggs Jason M. (Chief Financial Officer) Sale 660 90.00 59,400
2021-07-06 Meggs Jason M. (Chief Financial Officer) Option Ex 660 44.58 29,422
2021-06-30 Meggs Jason M. (Chief Financial Officer) Sale 4,668 90.00 420,120
2021-06-30 Meggs Jason M. (Chief Financial Officer) Option Ex 4,668 43.02 200,817
2021-06-07 Thl Equity Fund Vii Investors (inventiv), L.p. Sale 5,044,187 81.20 409,587,984
2021-06-07 Allen Tom Sale 6,307,489 81.20 512,168,106
2021-06-07 Advent International Gpe Viii-i Limited Partnership Sale 6,307,489 81.20 512,168,106
2021-06-07 Advent International Gpe Vii, Llc Sale 6,307,489 81.20 512,168,106
2021-06-07 Advent Partners Gpe Vii-a 2014 Cayman Limited Partnership Sale 6,307,489 81.20 512,168,106
2021-06-07 Advent International Gpe Vii-h Limited Partnership Sale 6,307,489 81.20 512,168,106
2021-06-07 Advent International Gpe Vii-c Limited Partnership Sale 6,307,489 81.20 512,168,106
2021-06-07 Maldonado John L. Sale 6,307,489 81.20 512,168,106
2021-06-01 Macdonald Alistair (Chief Executive Officer) Sale 4,889 88.20 431,209
2021-06-01 Macdonald Alistair (Chief Executive Officer) Option Ex 4,889 42.88 209,640
2021-05-14 Allen Tom Sale 448,942 81.04 36,382,259
2021-05-14 Advent Partners Gpe Viii-a Limited Partnership Sale 448,942 81.04 36,382,259
2021-05-14 Advent International Gpe Viii-i Limited Partnership Sale 448,942 81.04 36,382,259
2021-05-14 Advent International Gpe Vii, Llc Sale 448,942 81.04 36,382,259
2021-05-14 Advent Partners Gpe Vii-a 2014 Cayman Limited Partnership Sale 448,942 81.04 36,382,259
2021-05-14 Advent International Gpe Vii-g Limited Partnership Sale 448,942 81.04 36,382,259
2021-05-14 Advent International Gpe Vii-c Limited Partnership Sale 448,942 81.04 36,382,259
2021-05-12 Thl Holdco, Llc Sale 379,878 81.04 30,785,313
2021-05-12 Thl Equity Fund Vii Investors (inventiv), L.p. Sale 379,878 81.04 30,785,313
2021-05-06 Thl Holdco, Llc Sale 3,391,682 81.04 274,861,909
2021-05-06 Thl Equity Fund Vii Investors (inventiv), L.p. Sale 3,391,682 81.04 274,861,909
2021-05-06 Allen Tom Sale 4,008,318 81.04 324,834,090
2021-05-06 Advent International Gpe Viii-i Limited Partnership Sale 4,008,318 81.04 324,834,090
2021-05-06 Advent International Gpe Vii, Llc Sale 4,008,318 81.04 324,834,090
2021-05-06 Advent International Gpe Vii-h Limited Partnership Sale 4,008,318 81.04 324,834,090
2021-05-06 Advent International Gpe Vii-c Limited Partnership Sale 4,008,318 81.04 324,834,090
2021-05-06 Maldonado John L. Sale 4,008,318 81.04 324,834,090
2021-04-15 Keefe Michelle (Pres., Commercial Solutions) Sale 2,736 82.00 224,352
2021-04-15 Meggs Jason M. (Chief Financial Officer) Sale 6,000 84.00 504,000
2021-04-09 Macdonald Alistair (Chief Executive Officer) Sale 14,039 80.00 1,123,120
2021-03-31 Keefe Michelle (Pres., Commercial Solutions) Sale 2,000 78.00 156,000
2021-03-29 Olefson Jonathan (General Counsel & Corp Secty) Sale 4,000 77.00 308,000
2021-03-29 Harty Linda S (Director) Sale 7,310 76.49 559,141
2021-03-03 Kralowetz Donna Hildebrand (SVP, Chief Accounting Officer) Sale 248 74.64 18,510
2021-03-03 Thl Holdco, Llc Sale 3,995,954 74.17 296,399,887
2021-03-03 Thl Equity Fund Vii Investors (inventiv), L.p. Sale 3,995,954 74.17 296,399,887
2021-03-03 Allen Tom Sale 4,654,046 74.17 345,213,862
2021-03-03 Advent International Gpe Viii-i Limited Partnership Sale 4,654,046 74.17 345,213,862
2021-03-03 Advent International Gpe Vii, Llc Sale 4,654,046 74.17 345,213,862
2021-03-03 Advent Partners Gpe Vii-a 2014 Cayman Limited Partnership Sale 4,654,046 74.17 345,213,862
2021-03-03 Advent International Gpe Vii-h Limited Partnership Sale 4,654,046 74.17 345,213,862
2021-03-03 Advent International Gpe Vii-g Limited Partnership Sale 4,654,046 74.17 345,213,862
2021-03-03 Advent International Gpe Vii-c Limited Partnership Sale 4,654,046 74.17 345,213,862
2021-03-03 Maldonado John L. Sale 4,654,046 74.17 345,213,862
2021-03-02 Macdonald Alistair (Chief Executive Officer) Option Ex 36,429 .00 0
2021-02-16 Kralowetz Donna Hildebrand (SVP, Chief Accounting Officer) Sale 362 81.00 29,322
2021-02-02 Macdonald Alistair (Chief Executive Officer) Sale 278 77.11 21,437
2021-02-01 Macdonald Alistair (Chief Executive Officer) Sale 64,219 75.51 4,849,048
2021-02-01 Colvin Paul (Pres., Clinical Solutions) Sale 8,486 74.82 634,922
2021-01-25 Keefe Michelle (Pres., Commercial Solutions) Sale 4,000 75.68 302,720
2021-01-25 Olefson Jonathan (General Counsel & Corp Secty) Sale 5,336 75.68 403,828
2021-01-06 Meggs Jason M. (Chief Financial Officer) Sale 5,552 72.00 399,744
2020-12-23 Macdonald Alistair (Chief Executive Officer) Sale 300 70.52 21,155
2020-12-22 Macdonald Alistair (Chief Executive Officer) Sale 1,200 70.02 84,020
2020-12-03 Thl Holdco, Llc Sale 2,771,759 61.28 169,853,391
2020-12-03 Allen Tom Sale 3,228,241 61.28 197,826,608
2020-12-03 Advent International Gpe Viii-b Limited Partnership Sale 3,228,241 61.28 197,826,608
2020-12-03 Advent International Gpe Vii, Llc Sale 3,228,241 61.28 197,826,608
2020-12-03 Advent Partners Gpe Vii-a 2014 Cayman Limited Partnership Sale 3,228,241 61.28 197,826,608
2020-12-03 Advent International Gpe Vii-h Limited Partnership Sale 3,228,241 61.28 197,826,608
2020-12-03 Advent International Gpe Vii-c Limited Partnership Sale 3,228,241 61.28 197,826,608
2020-12-03 Advent International Gpe Vii-d Limited Partnership Sale 3,228,241 61.28 197,826,608
2020-12-03 Maldonado John L. Sale 3,228,241 61.28 197,826,608
2020-12-03 Nelson Joshua M Sale 2,771,759 61.28 169,853,391
2020-11-27 Meggs Jason M. (Chief Financial Officer) Sale 4,062 67.00 272,154
2020-11-24 Meggs Jason M. (Chief Financial Officer) Sale 1,938 67.00 129,846
2020-11-18 Keefe Michelle (Pres., Commercial Solutions) Sale 856 65.00 55,640
2020-11-17 Keefe Michelle (Pres., Commercial Solutions) Sale 800 62.65 50,120
2020-09-17 Thl Holdco, Llc Sale 3,233,719 59.26 191,630,187
2020-09-17 Allen Tom Sale 3,766,281 59.26 223,189,812
2020-09-17 Advent International Gpe Viii-b Limited Partnership Sale 3,766,281 59.26 223,189,812
2020-09-17 Advent International Gpe Vii, Llc Sale 3,766,281 59.26 223,189,812
2020-09-17 Advent Partners Gpe Vii-a 2014 Cayman Limited Partnership Sale 3,766,281 59.26 223,189,812
2020-09-17 Advent International Gpe Vii-c Limited Partnership Sale 3,766,281 59.26 223,189,812
2020-09-17 Advent International Gpe Vii-d Limited Partnership Sale 3,766,281 59.26 223,189,812
2020-09-17 Advent International Gpe Vii-e Limited Partnership Sale 3,766,281 59.26 223,189,812
2020-09-17 Maldonado John L. Sale 3,766,281 59.26 223,189,812
2020-09-17 Nelson Joshua M Sale 3,233,719 59.26 191,630,187
2020-08-03 Macdonald Alistair (Chief Executive Officer) Sale 10,289 65.07 669,464
2020-07-15 Macdonald Alistair (Chief Executive Officer) Sale 37,868 60.14 2,277,495
2020-07-15 Macdonald Alistair (Chief Executive Officer) Option Ex 37,868 16.06 608,160
2020-07-14 Macdonald Alistair (Chief Executive Officer) Sale 5,173 58.90 304,669
2020-07-14 Macdonald Alistair (Chief Executive Officer) Option Ex 5,173 10.57 54,678
2020-07-13 Macdonald Alistair (Chief Executive Officer) Sale 3,655 58.21 212,746
2020-07-13 Macdonald Alistair (Chief Executive Officer) Option Ex 3,655 10.57 38,633
2020-07-06 Keefe Michelle (Pres., Commercial Solutions) Sale 1,500 59.11 88,665
2020-07-06 Dineen John M. (Director) Buy 8,691 59.11 513,725
2020-05-20 Keefe Michelle (Pres., Commercial Solutions) Sale 2,500 60.00 150,000
2020-04-20 Parks Robert (EVP, Chief Accounting Officer) Sale 3,588 49.65 178,144
2020-03-20 Meggs Jason M. (Chief Financial Officer) Buy 3,555 36.38 129,313
2020-03-19 Colvin Paul (Pres., Clinical Solutions) Buy 1,300 36.65 47,645
2020-03-05 Meggs Jason M. (Chief Financial Officer) Option Ex 5,094 .00 0
2020-03-05 Macdonald Alistair (Chief Executive Officer) Option Ex 31,258 .00 0
2019-02-13 Macdonald Alistair (Chief Executive Officer) Sale 8,143 53.00 431,579
2019-02-13 Macdonald Alistair (Chief Executive Officer) Option Ex 8,143 8.45 68,808
2019-02-05 Macdonald Alistair (Chief Executive Officer) Sale 6,697 53.04 355,202
2019-02-05 Macdonald Alistair (Chief Executive Officer) Option Ex 6,697 8.45 56,589
2018-12-17 Olefson Jonathan (General Counsel & Corp Secty) Buy 750 41.27 30,954
2018-12-17 Meggs Jason M. (Chief Financial Officer) Buy 3,650 41.25 150,562
2018-08-09 Thl Equity Fund Vii Investors (inventiv), L.p. Sale 6,000,000 49.73 298,380,000
2018-01-22 Gaenzle Christopher L (CAO, GC & Sec) Sale 1,470 41.00 60,270
2017-09-18 Macdonald Alistair (Chief Executive Officer) Sale 2,348 54.60 128,200
2017-09-18 Gaenzle Christopher L (CAO, GC & Sec) Sale 4,682 54.55 255,426
2017-09-18 Rush Gregory S (Chief Financial Officer) Sale 9,703 54.48 528,600
2017-09-01 Gaenzle Christopher L (CAO, GC & Sec) Sale 42,601 58.77 2,503,873
2017-09-01 Gaenzle Christopher L (CAO, GC & Sec) Option Ex 42,601 12.23 521,010
2017-09-01 Rush Gregory S (Chief Financial Officer) Sale 88,739 58.81 5,218,651
2017-09-01 Rush Gregory S (Chief Financial Officer) Option Ex 98,739 22.08 2,180,157
2017-08-30 Rush Gregory S (Chief Financial Officer) Sale 41,420 58.24 2,412,466
2017-08-30 Rush Gregory S (Chief Financial Officer) Option Ex 41,420 13.06 540,945
2017-08-17 Macdonald Alistair (Chief Executive Officer) Sale 8,828 55.65 491,260
2017-08-17 Macdonald Alistair (Chief Executive Officer) Option Ex 8,828 10.57 93,311
2017-08-01 Gibertini Michael Option Ex 21,567 .00 0
2017-08-01 Macdonald Alistair (Chief Executive Officer) Option Ex 32,614 .00 0
2017-08-01 Gaenzle Christopher L (CAO, GC & Sec) Option Ex 18,330 .00 0
2017-08-01 Rush Gregory S (Executive VP and CFO) Option Ex 23,527 .00 0
2017-07-03 Macdonald Alistair (Chief Executive Officer) Sale 1,088 58.55 63,702
2017-07-03 Gaenzle Christopher L (CAO, GC & Sec) Sale 956 58.55 55,973
2017-06-30 Macdonald Alistair (Chief Executive Officer) Sale 9,467 58.36 552,456
2017-06-30 Macdonald Alistair (Chief Executive Officer) Option Ex 9,467 16.06 152,040
2017-06-30 Gaenzle Christopher L (CAO, GC & Sec) Sale 5,917 58.28 344,872
2017-06-30 Gaenzle Christopher L (CAO, GC & Sec) Option Ex 5,917 16.06 95,027
2017-05-01 Macdonald Alistair (Chief Executive Officer) Sale 9,467 45.00 426,015
2017-05-01 Macdonald Alistair (Chief Executive Officer) Option Ex 9,467 16.06 152,040
2017-04-03 Gaenzle Christopher L (CAO, GC & Sec) Sale 4,733 45.70 216,298
2017-04-03 Gaenzle Christopher L (CAO, GC & Sec) Option Ex 4,733 10.57 50,027
2017-03-03 Macdonald Alistair (Chief Executive Officer) Sale 8,828 45.00 397,260
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of INCR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Syneos Health, Inc. (symbol INCR, CIK number 1610950) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.